Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels
Conclusion
5-Aminosalicylic acid release profiles were variable among various commercially available formulations.
Funding
Shire Development LLC.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Asacol | Drugs & Pharmacology | Inflammatory Bowel Disease | Lialda | Pharmaceuticals | Study | Ulcerative Colitis